ACRS stock news

This page provides real-time market news, earnings updates, and company announcements related to Aclaris Therapeutics, Inc. (ACRS).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-04-09 12:20 EST

Aclaris: Fourth Quarter Financial Overview

101 finance2026-02-26 12:18:52

Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer

Finviz2026-03-12 11:33:46

Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis

Finviz2026-03-18 10:58:03

Aclaris has completed Bosakitug enrollment: 2026 data drivers establish a dual framework

101 finance2026-03-18 11:19:00

Profound Medical (PROF) Jumps 13.0%: Could This Signal Additional Upside?

101 finance2026-03-26 14:27:54

Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

Finviz2026-04-08 12:33:10

ACRS stock chart

ACRS stock details

ACRS stock price change

On the last trading day, ACRS stock closed at 3.75 USD, with a price change of -1.32% for the day.

Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

ACRS stock news